Pancreatic cancer
SkyFoundation
Funding science. Supporting patients.
Patient Resources
Article 03 of 067 min read

Treatment options

Treatment depends on the type, stage and overall health of the patient. Care is typically provided by a multidisciplinary team of surgeons, oncologists, gastroenterologists and palliative care specialists.

Treatment options
1

Surgery

Surgery is the only treatment with the potential to cure pancreatic cancer. However, only about 15–20% of patients are candidates, because the cancer is often diagnosed at an advanced stage.

Whipple procedure (pancreaticoduodenectomy). Removes the head of the pancreas along with part of the stomach, duodenum, bile duct and gallbladder. The most common surgery for tumors in the head of the pancreas.
Distal pancreatectomy. Removes the body and tail of the pancreas, often with the spleen.
Total pancreatectomy. Removes the entire pancreas, bile duct, gallbladder, and part of the stomach and small intestine. Patients require lifelong insulin and enzyme replacement.
Source
Johns Hopkins Medicine — Surgery for pancreatic cancer
2

Chemotherapy

Chemotherapy uses drugs that circulate throughout the body to kill cancer cells. It can be given neoadjuvant (before surgery, to shrink tumors and increase surgical success), adjuvant (after surgery, to reduce recurrence risk), or as primary treatment for locally advanced or metastatic disease.

FOLFIRINOX. A combination of fluorouracil, leucovorin, irinotecan and oxaliplatin — typically for patients in good health who can tolerate intensive therapy.
Gemcitabine with nab-paclitaxel. Often used when FOLFIRINOX is not appropriate.
Gemcitabine alone. An option for patients who cannot tolerate combination therapy.
Source
American Cancer Society — Chemotherapy for pancreatic cancer
3

Radiation therapy

Radiation uses high-energy X-rays to kill cancer cells. It may be used in combination with chemotherapy (chemoradiation) or alone.

To shrink borderline resectable tumors before surgery.
To control locally advanced cancer when surgery is not possible.
To relieve symptoms such as pain or bleeding.
Source
National Cancer Institute — Pancreatic cancer treatment
4

Targeted therapy and immunotherapy

Advances in genetics and molecular profiling have led to new treatment options for selected patients.

PARP inhibitors (such as olaparib). For patients with inherited BRCA1/2 or PALB2 mutations.
MSI-H or dMMR tumors. May respond to immunotherapy drugs such as pembrolizumab, a PD-1 inhibitor.
TRK fusion-positive tumors. May respond to TRK inhibitors such as larotrectinib.

Testing tumors for genetic changes — biomarker testing — is critical to determine eligibility.

Source
FDA — Drugs approved for pancreatic cancer
5

Palliative and supportive care

Palliative care is not only for end of life. It should begin at diagnosis to improve quality of life.

Pain management. Often involves medications, nerve blocks or celiac plexus neurolysis.
Digestive support. Pancreatic enzyme replacement therapy (PERT) helps manage malabsorption.
Nutritional counseling. Maintains weight and strength during treatment.
Psychological and social support. Reduces anxiety and caregiver stress.
Source
Cancer.Net — Palliative care for pancreatic cancer

Key takeaway

Treatment may involve surgery, systemic therapy, radiation, or a combination. Genetic and biomarker testing are increasingly important for guiding therapy, and palliative care should be integrated from the start.

Next article
Clinical trials access
SkyFoundation
PO Box 1780 · Birmingham, MI 48012
(248) 385-5143
© 2026 SKY FOUNDATION, INC · 501(c)(3) · EIN 26-2720583
PRIVACY POLICY
GIVE NOW